drugset / Trial / NCT02594449

A Pharmacodynamic and Safety Study of BCS in Healthy Volunteers

NCT02594449

Phase 4 Unknown 20 enrolled Lustre Pharmaceutical Lab Co., Ltd
RandomizedParallel-groupQuadruple-blind

Summary

To compare pharmacodynamics among the different concentrations of BCS and NS.

Timeline

Start
2015-10
Primary completion
2016-01
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator BENZALKONIUM Small molecule Other

Indications

No indication recorded.